Skip to main content

Purpose

To inform patients, and their family or carer, about the potential benefits and harms of acute pain treatment options so that they can participate in decision-making about their treatment with their clinician. This may or may not include opioid analgesics.

Endorsements

The Opioid Analgesic Stewardship in Acute Pain Clinical Care Standard was endorsed by the following organisations in 2022:

This was submitted last year but somehow not published
2022
Other resource

On 21 March 2022, the Australian Commission on Safety and Quality in Health Care, the Aged Care Quality and Safety Commission and the NDIS Quality and Safeguards Commission have launched the Joint Statement on the important issue of inappropriate use of psychotropic medicines with people with disability and older people as a form of restrictive practice, and committed to collaborative action to reduce it.

2022
Newsletter

This issue includes items on COVID-19, digital mental health standards, primary care, digital health, disruptive  behaviour and more.

Also covered are the latest issues of the Journal of Patient Safety and Risk Management and BMJ Quality & Safety, along with online first papers from BMJ Quality & Safety and the International Journal for Quality in Health Care  and the latest from the UK’s NICE.

Braille version

2022
Fact sheet or brochure

Developed by the Commission and endorsed by the Australian and New Zealand College of Anaesthetists this factsheet summarises the identification of neural route medicines, fluids and lines as described in the National standard for user-applied labelling of injectable medicines, fluids and lines.

2022
Newsletter

This issue includes items on COVID-19, digital health, antimicrobials/antibiotics, diagnosis and uncertainty, quality improvement and more.

Also covered are the latest issues of Public Health Research & Practice and Health Affairs, along with online first papers from BMJ Quality & Safety and the latest from the UK’s NICE.

Back to top